Bristol Myers’ pivotal year; Should AI be swinging bigger?; and more

Welcome back to Endpoints Weekly! The last week of April brought a downpour of news as several pharma companies reported their first-quarter earnings. Max Gelman took a close look at a make-or-break moment for Bristol ...